Has John Pennings, MD received payments from drug or device companies?

Yes. Drug and device makers reported $47,272 in general payments to John Pennings, MD across 77 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Pennings, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Pennings, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Pennings, MD

Surgery · Post Falls, IDNPI 1073569737

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Globus Medical accounts for 95.7% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $24,900 and has fallen 99.9% since, to $36 in 2025. Among surgery clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$47,272in general payments, 2019–2025

Across 77 payments — averaging $613.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Globus Medical$45K
Medtronic$1K
Intuitive Surgical$233
Johnson & Johnson$175
Alphatec Spine, Inc$149
Covidien LP$96
plus $256 from 8 others

What the payments were for

Consulting fees$12,54427%
Speaking & faculty fees$22,52548%
Travel & lodging$10,66823%
Food & beverage$1,5353%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Globus Medical(2 entities)	30	$45,246
Medtronic	22	$1,117
Intuitive Surgical	3	$233
Johnson & Johnson	7	$175
Alphatec Spine, Inc	1	$149
Covidien LP	3	$96
Baxter Healthcare	3	$82
Amgen	1	$46
W. L. Gore & Associates, Inc.	2	$35
Medical Device Business Services, Inc.	1	$23
Merck	1	$19
Encision Inc	1	$18
Baudax Bio Inc.	1	$18
Hologic Sales And Service, LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ALIF$25,445
EXCELSIUS$8,925
CORBEL$8,805
MARS 3VL Retractor$683
INTERSTIM$630
ALIF Retractor$531
CALIBER$392
CREO 5.5$174
IdentiTi$149
Excelsius Robotics System$127

How this compares

$47,272 in reported general payments places this provider in the 95th percentile of 136 surgery providers in Idaho.

See all surgery providers in Idaho →

Medicare billing

Part B allowed, 2024

$153,716

Medicare patients

252

Services billed

679

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	11	$27

Paid to pharmacies, not to this prescriber.